Carmell Therapeutics Corporation (CTCX)

NASDAQ: CTCX · IEX Real-Time Price · USD

1.090

-0.080 (-6.84%)

At close: Jul 19, 2024, 4:00 PM

1.110

+0.020 (1.83%)

Pre-market: Jul 20, 2024, 9:28 AM EDT

Carmell Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-7.94	-16.12	-9.61	-6.79
Depreciation & Amortization	0.12	0.12	0.24	0.24
Share-Based Compensation	0.7	0.67	0.64	0.25
Other Operating Activities	-1.83	6.3	4.74	4.81
Operating Cash Flow	-8.95	-8.35	-3.43	-1.18
Capital Expenditures	-0.03	-0.03	-0.01	-0.01
Acquisitions	-0.75	0	0	0
Investing Cash Flow	-0.78	-0.03	-0.01	-0.01
Share Issuance / Repurchase	30.99	30.99	-0	0.24
Debt Issued / Paid	-1.91	-1.34	2.36	1.12
Other Financing Activities	-18.49	-18.49	1.19	-0.17
Financing Cash Flow	10.59	11.16	3.55	1.2
Net Cash Flow	0.86	2.78	0.12	0.01
Free Cash Flow	-8.98	-8.38	-3.44	-1.18
Free Cash Flow Margin	-40.96%	-	-	-
Free Cash Flow Per Share	-0.39	-0.76	-1.96	-0.05

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).